-
< Back to Bill Search
-
Related Bills (5)
Bill Number Subject Filed By Last Action and Location Relationship Learn more about bill relationships H 1383 by Franklin
Pub. Rec./Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Last Action: 3/13/2026 H Died in Health Professions & Programs SubcommitteeLinked H 1385 by Franklin
Trust Funds/Creation/Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Last Action: 3/13/2026 H Died in Health Professions & Programs SubcommitteeLinked S 1552 by Burgess
Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Last Action: 3/13/2026 S Died in Health PolicyIdentical S 1554 by Burgess
Public Records/Experimental Treatment Outcomes
Last Action: 3/13/2026 S Died in Health PolicyCompare S 1556 by Burgess
Experimental Treatment Access Trust Fund/Department of Health
Last Action: 3/13/2026 S Died in Health PolicyCompare -
Citations - Statute (1)
The page numbers, when listed, for citations are constantly under review. The journals or printed bills of the respective chambers should be consulted as the official documents of the Legislature.
The links for the page numbers are formatted to open the bill text PDF directly to the page containing the citation. However, if your browser is set to open PDFs in a new window, as is often the case with 64-bit browsers, the bill text will open to the first page.499.0295 Experimental treatments for terminal conditions. Page 3 (pdf) -
Bill History
S = Senate, H = House
1/9/2026 H • Filed
1/13/2026 H • 1st Reading (Original Filed Version)
1/15/2026 H • Referred to Health Professions & Programs Subcommittee
• Referred to Health Care Budget Subcommittee
• Referred to Health & Human Services Committee
• Now in Health Professions & Programs Subcommittee
3/13/2026 H • Died in Health Professions & Programs Subcommittee
HB 1381: Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
GENERAL BILL by Franklin
Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases; Authorizes licensed physicians to prescribe & eligible facilities to administer experimental treatments; requires approval of specified platform or master protocol by institutional review board; requires DOH to establish & maintain patient registry; requires DOH to annually publish specified report; encourages health insurers & health maintenance organizations to provide specified insurance coverage for experimental treatments; authorizes licensed physicians & eligible facilities to receive reimbursement for experimental treatments; requires manufacturers of experimental treatments to provide for specified temporary price concession; requires DOH to adopt by rule certain procedures for licensing of experimental treatment centers.
Effective Date: upon becoming a law
Last Action: 3/13/2026 House - Died in Health Professions & Programs Subcommittee
Current Bill Version Posted: 1/9/2026 12:37 PM